Skip to content

A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy

A Prospective, Randomized, Single-blind, Parallel-controlled Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04102631
Enrollment
1076
Registered
2019-09-25
Start date
2019-08-30
Completion date
2019-12-31
Last updated
2019-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Detection Rate

Keywords

colonoscopy, computer vision, adenoma detection rate, Endo.Angel

Brief summary

Colonoscopy is a key technique in the detection and diagnosis of lower gastrointestinal diseases. High quality endoscopy results in better disease outcomes. However, the operant level of different endoscopists is significantly different.This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.

Detailed description

This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.Criteria for inclusion and exclusion are determined prior to endoscopic examination. Candidates who meet all inclusion criteria as well as do not meet all exclusion criteria are bring into the study. Participants randomized before the examination, they are divided into the exposed group assisted by Endo.Angel or the non-exposed group without Endo.Angel. Followup are conducted after the examination.Study will be finished when all followup is done,and the examination result collected from participants will send to an independent review data analysis group.

Interventions

Patients in exposed group will receive colonoscopy with assistance of Endo.Angel,a real-time quality monitoring system based on computer vision,which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.

Patients in non-exposed group will receive colonoscopy without assistance of Endo.Angel.

Sponsors

Renmin Hospital of Wuhan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Male or female aged 18 years or above; 2. Colonoscopy is needed to further characterize gastrointestinal diseases; 3. Ability to read, understand and sign informed consent forms; 4. The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.

Exclusion criteria

1. Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials. 2. Participate in a drug clinical trial and during the elution period of the trial or control drug 3. Drug or alcohol abuse or mental disorder in the last 5 years; 4. Pregnant or lactating women; 5. Patients with multiple polyp syndrome; 6. Patients with known space-occupying tumor or intestinal stenosis; 7. Patients with known perforation or colonic obstruction; 8. A history of anaphylaxis with antispasmodic has been documented; 9. The researchers did not consider the subjects suitable for colonoscopy; 10. The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate3 monthsThe numerator is the number of cases of adenoma detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.

Secondary

MeasureTime frameDescription
Polyp Detection Rate3 monthsThe numerator is the number of patients with polyps detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.
The mean number of adenomas per procedure3 monthsThe numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
Detection rate of large, small and minimal polyps3 monthsThe numerator was the number of patients with large (≥10 mm), small (4-9 mm), and minimal(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy
The mean number of large, small and minimal polyps per procedure3 monthsThe numerator was the number of large (≥10 mm), small (4-9 mm), and minimal (≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
Detection rate of large, small and minimal adenomas3 monthsThe numerator was the number of patients with large (≥10 mm), small (4-9 mm), and minimal(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy
The mean number of polyps per procedure3 monthsThe numerator is the total number of polyps detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
Detection rate of adenoma in different sites3 monthsThe numerator is the number of cases of adenoma detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
The mean number of adenomas in different sites per procedure3 monthsThe numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
Time of colonoscopic withdrawal3 monthsthe duration of colonoscopic withdrawal(not include the time of biopsy or treatment).
Time of colonoscopic insertion3 monthsThe time of colonoscopy from the rectum to the ileocecal area.
The rate of reaching the ileocecal region3 monthsThe numerator is the number of cases of colonic examination reaching the ileocecal region, and the denominator is the total number of colonoscopy cases.
The mean number of large, small and minimal adenomas per procedure3 monthsThe numerator was the number of large (≥10 mm), small (4-9 mm), and minimal (≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.

Countries

China

Contacts

Primary ContactHonggang Yu, MD
yuhonggang1968@163.com+8613871281899

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026